Biomarkers of Extracellular Matrix Metabolism (MMP-9 and TIMP-1) and Risk of Stroke, Myocardial Infarction, and Cause-Specific Mortality: Cohort Study

Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women

(2009) Barbara J. Jefferis et al.   ATHEROSCLEROSIS

Impact of plasma tissue inhibitor of metalloproteinase-1 on long-term survival in patients with gastric cancer

(2009) Takaki Yoshikawa et al.   Gastric Cancer

The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study

(2008) M. J. West et al.   EUROPEAN HEART JOURNAL

Tissue inhibitor of metalloproteinases levels in patients with chronic heart failure: An independent predictor of mortality

(2008) S. Frantz et al.   EUROPEAN JOURNAL OF HEART FAILURE

Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer

(2008) Zheng-Sheng Wu et al.   INTERNATIONAL JOURNAL OF CANCER

Circulating Matrix Metalloproteinase-9 Is Associated with Cardiovascular Risk Factors in a Middle-Aged Normal Population

(2008) Peter Garvin et al.   PLoS One

Matrix Metalloproteinase-8 and Tissue Inhibitor of Metalloproteinase-1 in Serum Do Not Reflect the Analytes Circulating in Blood

(2007) Klaus Jung   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY